To establish and validate deep learning (DL) models based on pre-treatment multiparametric magnetic resonance imaging (MRI) images of primary rectal cancer and basic clinical data for the prediction of synchronous liver metastases (SLM) in patients with Rectal cancer (RC). In this retrospective study, 176 and 31 patients with RC who underwent multiparametric MRI from two centers were enrolled in the primary and external validation cohorts, respectively. Clinical factors, including sex, primary tumor site, CEA level, and CA199 level were assessed. A clinical feature (CF) model was first developed by multivariate logistic regression, then two residual network DL models were constructed based on multiparametric MRI of primary cancer with or without CF incorporation. Finally, the SLM prediction models were validated by 5-fold cross-validation and external validation. The performance of the models was evaluated by decision curve analysis (DCA) and receiver operating characteristic (ROC) analysis. Among three SLM prediction models, the Combined DL model integrating primary tumor MRI and basic clinical data achieved the best performance (AUC = 0.887 in primary study cohort; AUC = 0.876 in the external validation cohort). In the primary study cohort, the CF model, MRI DL model, and Combined DL model achieved AUCs of 0.816 (95% CI: 0.750, 0.881), 0.788 (95% CI: 0.720, 0.857), and 0.887 (95% CI: 0.834, 0.940) respectively. In the external validation cohort, the CF model, DL model without CF, and DL model with CF achieved AUCs of 0.824 (95% CI: 0.664, 0.984), 0.662 (95% CI: 0.461, 0.863), and 0.876 (95% CI: 0.728, 1.000), respectively. The combined DL model demonstrates promising potential to predict SLM in patients with RC, thereby making individualized imaging test strategies. Accurate synchronous liver metastasis (SLM) risk stratification is important for treatment planning and prognosis improvement. The proposed DL signature may be employed to better understand an individual patient's SLM risk, aiding in treatment planning and selection of further imaging examinations to personalize clinical decisions. Not applicable.

Three-dimensional reconstruction of cortical surfaces from MRI for morphometric analysis is fundamental for understanding brain structure. While high-field MRI (HF-MRI) is standard in research and clinical settings, its limited availability hinders widespread use. Low-field MRI (LF-MRI), particularly portable systems, offers a cost-effective and accessible alternative. However, existing cortical surface analysis tools are optimized for high-resolution HF-MRI and struggle with the lower signal-to-noise ratio and resolution of LF-MRI. In this work, we present a machine learning method for 3D reconstruction and analysis of portable LF-MRI across a range of contrasts and resolutions. Our method works "out of the box" without retraining. It uses a 3D U-Net trained on synthetic LF-MRI to predict signed distance functions of cortical surfaces, followed by geometric processing to ensure topological accuracy. We evaluate our method using paired HF/LF-MRI scans of the same subjects, showing that LF-MRI surface reconstruction accuracy depends on acquisition parameters, including contrast type (T1 vs T2), orientation (axial vs isotropic), and resolution. A 3mm isotropic T2-weighted scan acquired in under 4 minutes, yields strong agreement with HF-derived surfaces: surface area correlates at r=0.96, cortical parcellations reach Dice=0.98, and gray matter volume achieves r=0.93. Cortical thickness remains more challenging with correlations up to r=0.70, reflecting the difficulty of sub-mm precision with 3mm voxels. We further validate our method on challenging postmortem LF-MRI, demonstrating its robustness. Our method represents a step toward enabling cortical surface analysis on portable LF-MRI. Code is available at https://surfer.nmr.mgh.harvard.edu/fswiki/ReconAny

Combined Pulmonary Fibrosis and Emphysema (CPFE), formally recognized as a distinct pulmonary syndrome in 2022, is characterized by unique clinical features and pathogenesis that may lead to respiratory failure and death. However, the diagnosis of CPFE presents significant challenges that hinder effective treatment. Here, we assembled three-dimensional (3D) reconstruction data of the chest High-Resolution Computed Tomography (HRCT) of patients from multiple hospitals across different provinces in China, including Xiangya Hospital, West China Hospital, and Fujian Provincial Hospital. Using this dataset, we developed CPFENet, a deep learning-based diagnostic model for CPFE. It accurately differentiates CPFE from COPD, with performance comparable to that of professional radiologists. Additionally, we developed a CPFE score based on radiomic analysis of 3D CT images to quantify disease characteristics. Notably, female patients demonstrated significantly higher CPFE scores than males, suggesting potential sex-specific differences in CPFE. Overall, our study establishes the first diagnostic framework for CPFE, providing a diagnostic model and clinical indicators that enable accurate classification and characterization of the syndrome.

The study aimed to develop machine learning (ML) models for pretherapy prediction of absorbed doses (ADs) in kidneys and tumoral lesions for metastatic castration-resistant prostate cancer (mCRPC) patients undergoing [¹⁷⁷Lu]Lu-PSMA-617 (Lu-PSMA) radioligand therapy (RLT). By leveraging radiomic features (RFs) from [⁶⁸Ga]Ga-PSMA-11 (Ga-PSMA) PET/CT scans and clinical biomarkers (CBs), the approach has the potential to improve patient selection and tailor dosimetry-guided therapy. Twenty patients with mCRPC underwent Ga-PSMA PET/CT scans prior to the administration of an initial 6.8±0.4 GBq dose of the first Lu-PSMA RLT cycle. Post-therapy dosimetry involved sequential scintigraphy imaging at approximately 4, 48, and 72 h, along with a SPECT/CT image at around 48 h, to calculate time-integrated activity (TIA) coefficients. Monte Carlo (MC) simulations, leveraging the Geant4 application for tomographic emission (GATE) toolkit, were employed to derive ADs. The ML models were trained using pretherapy RFs from Ga-PSMA PET/CT and CBs as input, while the ADs in kidneys and lesions (n=130), determined using MC simulations from scintigraphy and SPECT imaging, served as the ground truth. Model performance was assessed through leave-one-out cross-validation (LOOCV), with evaluation metrics including R² and root mean squared error (RMSE). The mean delivered ADs were 0.88 ± 0.34 Gy/GBq for kidneys and 2.36 ± 2.10 Gy/GBq for lesions. Combining CBs with the best RFs produced optimal results: the extra trees regressor (ETR) was the best ML model for predicting kidney ADs, achieving an RMSE of 0.11 Gy/GBq and an R² of 0.87. For lesion ADs, the gradient boosting regressor (GBR) performed best, with an RMSE of 1.04 Gy/GBq and an R² of 0.77. Integrating pretherapy Ga-PSMA PET/CT RFs with CBs shows potential in predicting ADs in RLT. To personalize treatment planning and enhance patient stratification, it is crucial to validate these preliminary findings with a larger sample size and an independent cohort.

Reconstructing natural images from functional magnetic resonance imaging (fMRI) data remains a core challenge in natural decoding due to the mismatch between the richness of visual stimuli and the noisy, low resolution nature of fMRI signals. While recent two-stage models, combining deep variational autoencoders (VAEs) with diffusion models, have advanced this task, they treat all spatial-frequency components of the input equally. This uniform treatment forces the model to extract meaning features and suppress irrelevant noise simultaneously, limiting its effectiveness. We introduce FreqSelect, a lightweight, adaptive module that selectively filters spatial-frequency bands before encoding. By dynamically emphasizing frequencies that are most predictive of brain activity and suppressing those that are uninformative, FreqSelect acts as a content-aware gate between image features and natural data. It integrates seamlessly into standard very deep VAE-diffusion pipelines and requires no additional supervision. Evaluated on the Natural Scenes dataset, FreqSelect consistently improves reconstruction quality across both low- and high-level metrics. Beyond performance gains, the learned frequency-selection patterns offer interpretable insights into how different visual frequencies are represented in the brain. Our method generalizes across subjects and scenes, and holds promise for extension to other neuroimaging modalities, offering a principled approach to enhancing both decoding accuracy and neuroscientific interpretability.

The rapid advancement of Large Language Models (LLMs) has stimulated interest in multi-agent collaboration for addressing complex medical tasks. However, the practical advantages of multi-agent collaboration approaches remain insufficiently understood. Existing evaluations often lack generalizability, failing to cover diverse tasks reflective of real-world clinical practice, and frequently omit rigorous comparisons against both single-LLM-based and established conventional methods. To address this critical gap, we introduce MedAgentBoard, a comprehensive benchmark for the systematic evaluation of multi-agent collaboration, single-LLM, and conventional approaches. MedAgentBoard encompasses four diverse medical task categories: (1) medical (visual) question answering, (2) lay summary generation, (3) structured Electronic Health Record (EHR) predictive modeling, and (4) clinical workflow automation, across text, medical images, and structured EHR data. Our extensive experiments reveal a nuanced landscape: while multi-agent collaboration demonstrates benefits in specific scenarios, such as enhancing task completeness in clinical workflow automation, it does not consistently outperform advanced single LLMs (e.g., in textual medical QA) or, critically, specialized conventional methods that generally maintain better performance in tasks like medical VQA and EHR-based prediction. MedAgentBoard offers a vital resource and actionable insights, emphasizing the necessity of a task-specific, evidence-based approach to selecting and developing AI solutions in medicine. It underscores that the inherent complexity and overhead of multi-agent collaboration must be carefully weighed against tangible performance gains. All code, datasets, detailed prompts, and experimental results are open-sourced at https://medagentboard.netlify.app/.

Multimodal medical image fusion plays a crucial role in medical diagnosis by integrating complementary information from different modalities to enhance image readability and clinical applicability. However, existing methods mainly follow computer vision standards for feature extraction and fusion strategy formulation, overlooking the rich semantic information inherent in medical images. To address this limitation, we propose a novel semantic-guided medical image fusion approach that, for the first time, incorporates medical prior knowledge into the fusion process. Specifically, we construct a publicly available multimodal medical image-text dataset, upon which text descriptions generated by BiomedGPT are encoded and semantically aligned with image features in a high-dimensional space via a semantic interaction alignment module. During this process, a cross attention based linear transformation automatically maps the relationship between textual and visual features to facilitate comprehensive learning. The aligned features are then embedded into a text-injection module for further feature-level fusion. Unlike traditional methods, we further generate diagnostic reports from the fused images to assess the preservation of medical information. Additionally, we design a medical semantic loss function to enhance the retention of textual cues from the source images. Experimental results on test datasets demonstrate that the proposed method achieves superior performance in both qualitative and quantitative evaluations while preserving more critical medical information.

Low-dose CT (LDCT) images are often accompanied by significant noise, which negatively impacts image quality and subsequent diagnostic accuracy. To address the challenges of multi-scale feature fusion and diverse noise distribution patterns in LDCT denoising, this paper introduces an innovative model, CTLformer, which combines convolutional structures with transformer architecture. Two key innovations are proposed: a multi-scale attention mechanism and a dynamic attention control mechanism. The multi-scale attention mechanism, implemented through the Token2Token mechanism and self-attention interaction modules, effectively captures both fine details and global structures at different scales, enhancing relevant features and suppressing noise. The dynamic attention control mechanism adapts the attention distribution based on the noise characteristics of the input image, focusing on high-noise regions while preserving details in low-noise areas, thereby enhancing robustness and improving denoising performance. Furthermore, CTLformer integrates convolutional layers for efficient feature extraction and uses overlapping inference to mitigate boundary artifacts, further strengthening its denoising capability. Experimental results on the 2016 National Institutes of Health AAPM Mayo Clinic LDCT Challenge dataset demonstrate that CTLformer significantly outperforms existing methods in both denoising performance and model efficiency, greatly improving the quality of LDCT images. The proposed CTLformer not only provides an efficient solution for LDCT denoising but also shows broad potential in medical image analysis, especially for clinical applications dealing with complex noise patterns.

Prostate cancer is one of the most common and lethal cancers among men, making its early detection critically important. Although ultrasound imaging offers greater accessibility and cost-effectiveness compared to MRI, traditional transrectal ultrasound methods suffer from low sensitivity, especially in detecting anteriorly located tumors. Ultrasound computed tomography provides quantitative tissue characterization, but its clinical implementation faces significant challenges, particularly under anatomically constrained limited-angle acquisition conditions specific to prostate imaging. To address these unmet needs, we introduce OpenPros, the first large-scale benchmark dataset explicitly developed for limited-view prostate USCT. Our dataset includes over 280,000 paired samples of realistic 2D speed-of-sound (SOS) phantoms and corresponding ultrasound full-waveform data, generated from anatomically accurate 3D digital prostate models derived from real clinical MRI/CT scans and ex vivo ultrasound measurements, annotated by medical experts. Simulations are conducted under clinically realistic configurations using advanced finite-difference time-domain and Runge-Kutta acoustic wave solvers, both provided as open-source components. Through comprehensive baseline experiments, we demonstrate that state-of-the-art deep learning methods surpass traditional physics-based approaches in both inference efficiency and reconstruction accuracy. Nevertheless, current deep learning models still fall short of delivering clinically acceptable high-resolution images with sufficient accuracy. By publicly releasing OpenPros, we aim to encourage the development of advanced machine learning algorithms capable of bridging this performance gap and producing clinically usable, high-resolution, and highly accurate prostate ultrasound images. The dataset is publicly accessible at https://open-pros.github.io/.

Existing semi-supervised medical segmentation co-learning frameworks have realized that model performance can be diminished by the biases in model recognition caused by low-quality pseudo-labels. Due to the averaging nature of their pseudo-label integration strategy, they fail to explore the reliability of pseudo-labels from different sources. In this paper, we propose a mutual evidential deep learning (MEDL) framework that offers a potentially viable solution for pseudo-label generation in semi-supervised learning from two perspectives. First, we introduce networks with different architectures to generate complementary evidence for unlabeled samples and adopt an improved class-aware evidential fusion to guide the confident synthesis of evidential predictions sourced from diverse architectural networks. Second, utilizing the uncertainty in the fused evidence, we design an asymptotic Fisher information-based evidential learning strategy. This strategy enables the model to initially focus on unlabeled samples with more reliable pseudo-labels, gradually shifting attention to samples with lower-quality pseudo-labels while avoiding over-penalization of mislabeled classes in high data uncertainty samples. Additionally, for labeled data, we continue to adopt an uncertainty-driven asymptotic learning strategy, gradually guiding the model to focus on challenging voxels. Extensive experiments on five mainstream datasets have demonstrated that MEDL achieves state-of-the-art performance.